2011•Zhongguo yaofangRequires access

Efficacy Observation of Shenkang Injection in the Treatment of Primary Nephrotic Syndrome

Dang Yong

Open publisher page 0 citations

Abstract

OBJECTIVE:To observe the therapeutic efficacy of Shenkang injection in the treatment of primary nephrotic syndrome.METHODS:A total of 100 patients with primary nephrotic syndrome were randomly divided into two groups.On the basis of traditional therapy,treatment group(50 cases) was given intravenous injection of Shenkang injection.Control group(50 cases) was given intravenous injection of Danshen injection.28 days later,therapeutic efficacies and the levels of urine protein(UP),serum albumin(ALB),serum creation(Scr) and urea nitroger(BUN) were observed.RESULTS:The therapeutic efficacy of treatment group was better than that of control group,and the overall effective rate was 90%.The levels of serum albumin increased significantly(P0.05),and the levels of urine protein,blood urea nitrogen,and serum creatinine decreased significantly(P0.05).CONCLUSION:Shenkang injection effective in the treatment of primary nephrotic syndrome with less side effect and good compliance.

About this research paper

What this paper is about

OBJECTIVE:To observe the therapeutic efficacy of Shenkang injection in the treatment of primary nephrotic syndrome.METHODS:A total of 100 patients with primary nephrotic syndrome were randomly divided into two groups.On the basis of traditional therapy,treatment group(50 cases) was given intravenous injection of Shenkang injection.Control group(50 cases) was given intravenous injection of Danshen injection.28 days later,therapeutic efficacies and the levels of urine protein(UP),serum albumin(ALB),serum creation(Scr) and urea nitroger(BUN) were observed.RESULTS:The therapeutic efficacy of treatment group was better than that of control group,and the overall effective rate was 90%.The levels of serum albumin increased significantly(P0.05),and the levels of urine protein,blood urea nitrogen,and serum creatinine decreased significantly(P0.05).CONCLUSION:Shenkang injection effective in the treatment of primary nephrotic syndrome with less side effect and good compliance.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To observe the therapeutic efficacy of Shenkang injection in the treatment of primary nephrotic syndrome.METHODS:A total of 100 patients with primary nephrotic syndrome were randomly divided into two groups.On the basis of traditional therapy,treatment group(50 cases) was given intravenous injection of Shenkang injection.Control group(50 cases) was given intravenous injection of Danshen injection.28 days later,therapeutic efficacies and the levels of urine protein(UP),serum albumin(ALB),serum creation(Scr) and urea nitroger(BUN) were observed.RESULTS:The therapeutic efficacy of treatment group was better than that of control group,and the overall effective rate was 90%.The levels of serum albumin increased significantly(P0.05),and the levels of urine protein,blood urea nitrogen,and serum creatinine decreased significantly(P0.05).CONCLUSION:Shenkang injection effective in the treatment of primary nephrotic syndrome with less side effect and good compliance.

Key concepts: Nephrotic syndrome, Medicine, Creatinine, Blood urea nitrogen, Urine, Albumin, Therapeutic effect, Clinical efficacy

Related papers

Back to paper searchBrowse research topicsOriginal source
Efficacy Observation of Shenkang Injection in the Treatment of Primary Nephrotic Syndrome — Research Paper | ScholarLens